Could Ephedrine Replace Dexmedetomidine Fordexmedetomidine Prevention of Shivering in Women Undergoing Cesarean Section Under Spinal Anaesthesia
Launched by ASSIUT UNIVERSITY · Jan 22, 2024
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a medication called ephedrine can be used instead of another medication called dexmedetomidine to help prevent shivering in women who are having a cesarean section with spinal anesthesia. Shivering can be a common side effect of the anesthesia, and the goal is to find the most effective way to keep patients comfortable during and after the surgery.
To be part of this study, participants need to be women aged 18 to 35 who are having a straightforward pregnancy and are scheduled for an elective cesarean delivery. Women who refuse to participate, have allergies to the medications, have certain health conditions like diabetes or thyroid disorders, or cannot safely receive spinal anesthesia will not be eligible. Those who join the trial can expect to receive either ephedrine or dexmedetomidine and will be monitored for their comfort and any side effects during the procedure. This research aims to improve care and comfort for future patients undergoing similar surgeries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult female from 18 to 35 yrs
- • uncomplicated pregnancy for elective cesarean delivery
- Exclusion Criteria:
- • patient refusal
- • allergy to the drug
- • contraindications of spinal anaesthesia
- • patients with DM or thyroid disorders
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported